Frataxin participates to the hypoxia-induced response in tumors

Cell Death and Disease

Volumn 2, Issue 2, 2011, Pages

  Guccini, I ^a   Serio, D ^a   Condo I ^a   Rufini, A ^a   Tomassini, B ^a   Mangiola, A ^b   Maira, G ^b   Anile, C ^b   Fina, D ^a   Pallone, F ^a   Mongiardi, M P ^c   Levi, A ^c   Ventura, N ^a   Testi, R ^a   Malisan, F ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c CNR   (Italy)

Author keywords

Frataxin; Friedreich's ataxia; HIF; Hypoxia; p53; Tumor

Indexed keywords

FRATAXIN; HYPOXIA INDUCIBLE FACTOR; PROTEIN P53; IRON BINDING PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; ANOXIA; APOPTOSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; TUMOR CELL LINE;

ANOXIA; APOPTOSIS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IRON-BINDING PROTEINS; NEOPLASMS; OXIDATIVE STRESS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 79959780001     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2011.5     Document Type: Article

References (40)

1. Schmucker S, Puccio H. Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches. Hum Mol Genet 2010; 19: R103-R110.
2. Cossee M, Puccio H, Gansmuller A, Koutnikova H, Dierich A, LeMeur M et al. Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum Mol Genet 2000; 9: 1219-1226. (Pubitemid 30248608)
3. Vazzola V, Losa A, Soave C, Murgia I. Knockout of frataxin gene causes embryo lethality in Arabidopsis. FEBS Lett 2007; 581: 667-672. (Pubitemid 46216291)
4. Ventura N, Rea S, Henderson ST, Condo I, Johnson TE, Testi R. Reduced expression of frataxin extends the lifespan of Caenorhabditis elegans. Aging Cell 2005; 4: 109-112. (Pubitemid 41632910)
5. Richardson DR, Huang ML, Whitnall M, Becker EM, Ponka P, Rahmanto YS. The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich's ataxia. J Mol Med 2010; 88: 323-329.
6. Stemmler TL, Lesuisse E, Pain D, Dancis A. Frataxin and mitochondrial Fe-S cluster biogenesis. J Biol Chem 2010; 285: 26737-26743.
7. Condo I, Ventura N, Malisan F, Tomassini B, Testi R. A pool of extramitochondrial frataxin that promotes cell survival. J Biol Chem 2006; 281: 16750-16756.
8. Stehling O, Elsasser HP, Bruckel B, Muhlenhoff U, Lill R. Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Hum Mol Genet 2004; 13: 3007-3015. (Pubitemid 39585233)
9. Thierbach R, Schulz TJ, Isken F, Voigt A, Mietzner B, Drewes G et al. Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. Hum Mol Genet 2005; 14: 3857-3864. (Pubitemid 43020087)
10. Calmels N, Seznec H, Villa P, Reutenauer L, Hibert M, Haiech J et al. Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen. BMC Neurol 2009; 9: 46.
11. Schulz TJ, Thierbach R, Voigt A, Drewes G, Mietzner B, Steinberg P et al. Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited. J Biol Chem 2006; 281: 977-981.
12. Gottesfeld JM. Small molecules affecting transcription in Friedreich ataxia. Pharmacol Ther 2007; 116: 236-248. (Pubitemid 47469990)
13. Marmolino D, Acquaviva F, Pinelli M, Monticelli A, Castaldo I, Filla A et al. PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy. Cerebellum 2009; 8: 98-103.
14. Oktay Y, Dioum E, Matsuzaki S, Ding K, Yan LJ, Haller RG et al. Hypoxia-inducible factor 2alpha regulates expression of the mitochondrial aconitase chaperone protein frataxin. J Biol Chem 2007; 282: 11750-11756. (Pubitemid 47100692)
15. Michieli P. Hypoxia, angiogenesis and cancer therapy: to breathe or not to breathe? Cell Cycle 2009; 8: 3291-3296.
16. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010; 29: 625-634.
17. Semenza GL. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 2010; 20: 51-56.
18. Lofstedt T, Fredlund E, Holmquist-Mengelbier L, Pietras A, Ovenberger M, Poellinger L et al. Hypoxia inducible factor-2alpha in cancer. Cell Cycle 2007; 6: 919-926.
19. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998; 392: 405-408.
20. Schmid T, Zhou J, Brune B. HIF-1 and p53: communication of transcription factors under hypoxia. J Cell Mol Med 2004; 8: 423-431. (Pubitemid 44145475)
21. Bertout JA, Majmundar AJ, Gordan JD, Lam JC, Ditsworth D, Keith B et al. HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proc Natl Acad Sci USA 2009; 106: 14391-14396.
22. Vousden KH, Ryan KM. p53 and metabolism. Nat Rev Cancer 2009; 9: 691-700.
23. Solaini G, Baracca A, Lenaz G, Sgarbi G. Hypoxia and mitochondrial oxidative metabolism. Biochim Biophys Acta 2010; 1797: 1171-1177.
24. Karawajew L, Rhein P, Czerwony G, Ludwig WD. Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. Blood 2005; 105: 4767-4775. (Pubitemid 40807302)
25. Armstrong JS, Khdour O, Hecht SM. Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question. Faseb J 2010; 24: 2152-2163.
26. Ventura N, Rea SL, Schiavi A, Torgovnick A, Testi R, Johnson TE. p53/CEP-1 increases or decreases lifespan, depending on level of mitochondrial bioenergetic stress. Aging Cell 2009; 8: 380-393.
27. Torgovnick A, Schiavi A, Testi R, Ventura N. A role for p53 in mitochondrial stress response control of longevity in C. elegans. Exp Gerontol 2010; 45: 550-557.
28. Paupe V, Dassa EP, Goncalves S, Auchere F, Lonn M, Holmgren A et al. Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. PLoS One 2009; 4: e4253.
29. Rufini A, Fortuni S, Arcuri G, Condo I, Serio D, Incani O et al. Preventing the ubiquitin/proteasome-dependent degradation of frataxin, the protein defective in Friedreich's Ataxia. Hum Mol Genet 2011, doi: 10.1093/hmg/ddq566.
30. Fiorenzo P, Mongiardi MP, Dimitri D, Cozzolino M, Ferri A, Montano N et al. HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo. Int J Oncol 2010; 36: 785-791.
31. Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, Yan LJ et al. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat Genet 2003; 35: 331-340. (Pubitemid 37486916)
32. Lu H, Li Y, Shu M, Tang J, Huang Y, Zhou Y et al. Hypoxia-inducible factor-1alpha blocks differentiation of malignant gliomas. FEBS J 2009; 276: 7291-7304.
33. Lane DJ, Richardson DR. Frataxin, a molecule of mystery: trading stability for function in its iron-binding site. Biochem J 2010; 426: e1-e3.
34. Huang ML, Becker EM, Whitnall M, Rahmanto YS, Ponka P, Richardson DR. Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant. Proc Natl Acad Sci USA 2009; 106: 16381-16386.
35. Mastrogiannaki M, Matak P, Keith B, Simon MC, Vaulont S, Peyssonnaux C. HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J Clin Invest 2009; 119: 1159-1166.
36. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, Loscalzo J. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 2009; 10: 273-284.
37. Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, Crosby M et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS One 2010; 5: e10345.
38. Taylor CT. Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J 2008; 409: 19-26.
39. Haugen AC, Di Prospero NA, Parker JS, Fannin RD, Chou J, Meyer JN et al. Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology. PLoS Genet 2010; 6: e1000812.
40. Lu C, Cortopassi G. Frataxin knockdown causes loss of cytoplasmic iron-sulfur cluster functions, redox alterations and induction of heme transcripts. Arch Biochem Biophys 2007; 457: 111-122. (Pubitemid 44969278)